The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
The Treatment of Hallucinations in Schizophrenia Spectrum Disorders
Open accessAbstract
This article reviews the treatment of hallucinations in schizophrenia. The first treatment option for hallucinations in schizophrenia is antipsychotic medication, which can induce a rapid decrease in severity. Only 8% of first-episode patients still experience mild to moderate hallucinations after continuing medication for 1 year. Olanzapine, amisulpride, ziprasidone, and quetiapine are equally effective against hallucinations, but haloperidol may be slightly inferior. If the drug of first choice provides inadequate improvement, it is probably best to switch medication after 2-4 weeks of treatment. Clozapine is the drug of choice for patients who are resistant to 2 antipsychotic agents. Blood levels should be above 350-450 μg/ml for maximal effect. For relapse prevention, medication should be continued in the same dose. Depot medication should be considered for all patients because nonadherence is high. Cognitive-behavioral therapy (CBT) can be applied as an augmentation to antipsychotic medication. The success of CBT depends on the reduction of catastrophic appraisals, thereby reducing the concurrent anxiety and distress. CBT aims at reducing the emotional distress associated with auditory hallucinations and develops new coping strategies. Transcranial magnetic stimulation (TMS) is capable of reducing the frequency and severity of auditory hallucinations. Several meta-analyses found significantly better symptom reduction for low-frequency repetitive TMS as compared with placebo. Consequently, TMS currently has the status of a potentially useful treatment method for auditory hallucinations, but only in combination with state of the art antipsychotic treatment. Electroconvulsive therapy (ECT) is considered a last resort for treatment-resistant psychosis. Although several studies showed clinical improvement, a specific reduction in hallucination severity has never been demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm114 · Cited by 1,029 · cited 1×
“1.(15) Group therapy, however, has not yielded any clinically significant results.”
BackgroundBach, P., & Hayes, S. C. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.5.1129 · Cited by 839
Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., & Korhonen, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081224 · Cited by 619
Delirium epidemiology in critical care (DECCA): an international study
Salluh, J. I., Soares, M., Teles, J. M., Ceraso, D., Raimondi, N., Nava, V. S., Blasquez, P., Ugarte, S., Ibanez-Guzman, C., Centeno, J. V., et al. (2010) · Critical Care · doi:10.1186/cc9333 · Cited by 373
Sultzer, D. L., Davis, S. M., Tariot, P. N., Dagerman, K. S., Lebowitz, B. D., Lyketsos, C. G., Rosenheck, R. A., Hsiao, J. K., Lieberman, J. A., Schneider, L. S., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111779 · Cited by 321
Bebbington, P., Jonas, S., Kuipers, E., King, M., Cooper, C., Brugha, T., Meltzer, H., McManus, S., & Jenkins, R. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.083642 · Cited by 272
Cognitive therapy for command hallucinations: randomised controlled trial
Trower, P., Birchwood, M., Meaden, A., Byrne, S., Nelson, A., & Ross, K. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.4.312 · Cited by 268
Compassionate mind training with people who hear malevolent voices: A case series report
Mayhew, S. L., & Gilbert, P. (2008) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.566 · Cited by 259
Testing for the Presence of Positive-Outcome Bias in Peer Review: A Randomized Controlled Trial
Emerson, G. B., Warme, W. J., Wolf, F. M., Heckman, J. D., Brand, R. A., & Leopold, S. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.406 · Cited by 245 · cited 1×
“In other areas of research, such trends have led effect sizes to decrease per year of publication.(35) As rTMS is a relatively young treatment method, future studies may well show less favorable results than the initial ones.”
Result
Cited by
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
Kesby, J., Eyles, D., McGrath, J., & Scott, J. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0071-9 · Cited by 352
From adversity to psychosis: pathways and mechanisms from specific adversities to specific symptoms
Bentall, R. P., de Sousa, P., Varese, F., Wickham, S., Sitko, K., Haarmans, M., & Read, J. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0914-0 · Cited by 320
Optimal trajectories of brain state transitions
Gu, S., Betzel, R. F., Mattar, M. G., Cieslak, M., Delio, P. R., Grafton, S. T., Pasqualetti, F., & Bassett, D. S. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.01.003 · Cited by 183
A perceptual inference mechanism for hallucinations linked to striatal dopamine
Cassidy, C. M., Balsam, P. D., Weinstein, J. J., Rosengard, R. J., Slifstein, M., Daw, N. D., Abi-Dargham, A., & Horga, G. (2018) · Current Biology · doi:10.1016/j.cub.2017.12.059 · Cited by 176
“Such auditory hallucinations and other cardinal psychotic symptoms respond to antidopaminergic treatment [3], worsen with prodopaminergic drugs [4, 5], and their severity—beyond a categorical diagnosis of schizophrenia—correlates with excessive dopamine release in the associative striatum [6, 7].”
BackgroundRelating Therapy for distressing auditory hallucinations: A pilot randomized controlled trial
Hayward, M., Jones, A.-M., Bogen-Johnston, L., Thomas, N., & Strauss, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.019 · Cited by 128
Metadata
- Authors
- Sommer, I. E. C., Slotema, C. W., Daskalakis, Z. J., Derks, E. M., Blom, J. D., & van der Gaag, M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-24
- Volume
- 38
- Issue
- 4
- Pages
- 704-714
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2161446816
- Cited by
- 194
- References
- 14
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Treatment of Hallucinations in Schizophrenia Spectrum Disorders. https://app.cochat.ai/papers/10.1093/schbul/sbs034
- The paper
- Sommer, I. E. C., Slotema, C. W., Daskalakis, Z. J., Derks, E. M., Blom, J. D., & van der Gaag, M. (2012). The Treatment of Hallucinations in Schizophrenia Spectrum Disorders. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbs034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.